Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Medrxiv : the Preprint Server for Health Sciences|July 13, 2022
Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccinationPriscilla Ramos Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, et al.
Frontiers in Immunology|August 1, 2022
Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta VariantKevin Paul, Freya Sibbertsen, Daniela Weiskopf, et al.
Cell Reports. Medicine|February 1, 2021
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 casesAlison Tarke, John Sidney, Conner K Kidd, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 casesAlison Tarke, John Sidney, Conner K Kidd, et al.
Frontiers in Immunology|November 7, 2022
Humoral and cellular immune responses to CoronaVac up to one year after vaccinationPriscilla Ramos Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Cell Reports|December 1, 2021
Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sexMaya M L Poon, Eve Byington, Wenzhao Meng, et al.
Vaccine|June 18, 2024
Proceedings of the dengue endgame summit: Imagining a world with dengue controlAdam D Wegman, Shirin Kalimuddin, Ernesto T A Marques, et al.
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Nature Microbiology|June 10, 2022
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concernRajesh Vikkurthi, Asgar Ansari, Anupama R Pai, et al.
Pageof 23